Clinical trial · Interventional
Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
NCT01641276CI-TRIAL-00019107THBC-HSL2completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The propose of this study is to identification of a group of specific amplitude-modulated frequencies of low intensity electromagnetic fields that is associated with biofeedback upon exposure to in patients with hepatitis B carries with or without hepatocellular carcinoma.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatitis | — | UNRESOLVED | — |
| Hepatocellular Carcinomas | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Low intensity amplitude-moduled electromagnetic fields | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- hepatitis
- description
- hepatitis B carriers patients
- interventionNames
- Device: Low intensity amplitude-moduled electromagnetic fields
- type
- EXPERIMENTAL
- label
- hepatocellular carcinoma patients
- description
- hepatites B carriers patients with associated hepatocellular carcinoma
- interventionNames
- Device: Low intensity amplitude-moduled electromagnetic fields
Primary outcomes (1)
- measure
- Identification of different group of specific frequencies of modulation in hepatitis B carriers with and without hepatocellular carcinoma associated with biofeedback response
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * hepatitis B carriers patients * hepatitis B carriers patients with hepatocellular cancer patients Exclusion Criteria: * other tumor types * other hepatitis types
References
Publications (0)
Data not yet available
No reference posted for this study.